CRISPR gene therapy against AIDS

Lymphocyte infected by an HIV virus. The new CRISPR derived gene therapy helps avoid infection — HIV-infected H9 T-cell. Credit: NIAID

After the big scandal of the CRISPR babies at the end of 2018, some might have thought that would be the end of CRISPR in the clinic, but luckily that has not been the case and despite the public outrage of last year, today we can report on its successful use as gene therapy against AIDS.

Share this